Home › Colorectal Cancer › Nebraska › Omaha
Pag-aaral pangklinika para sa Colorectal Cancer sa Omaha, NE
Isang pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Omaha. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Family Communications After Genetic Testing
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
Nagre-recruitPhase 2
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · 9 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Nagre-recruitPhase 1
- Exelixis Clinical Site #2, Omaha
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Nebraska Cancer Specialists, Omaha
- XCancer, Omaha
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Nagre-recruitPhase 2
- Nebraska Cancer Specialists - Omaha - Wright Street /ID# 271646, Omaha
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Nagre-recruitPhase 3
- Nebraska Cancer Specialists, Omaha
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Nagre-recruitPhase 3
- Nebraska Cancer Specialists Midwest Cancer Center, Omaha
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
Nagre-recruitPhase 2/3
- University Of Nebraska Medical Center, Omaha
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Nagre-recruitPhase 1/2
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
Nagre-recruitPhase 3
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Methodist, Omaha
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan, Omaha
- Oncology Hematology West, PC dba Nebraska Cancer Specialists - Legacy, Omaha
- at 2 pa
A Study to Investigate CEA-PRIT 2.0 in Participants With Metastatic Colorectal Cancer (mCRC)
Nagre-recruitPhase 1
- Nebraska Cancer Specialists, Omaha
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
Nagre-recruitPhase 2
- Nebraska Cancer Specialists, Omaha
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Nagre-recruitPhase 1/2
- Nebraska Cancer Specialists, Omaha
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Nagre-recruitPhase 1
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
- Alegent Health Immanuel Medical Center, Omaha
- Alegent Health Bergan Mercy Medical Center, Omaha
- Alegent Health Lakeside Hospital, Omaha
- at 1 pa
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Nebraska Cancer Specialists, Omaha
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Nagre-recruitObservasyonal na pag-aaral
- Nebraska Cancer Specialists, Omaha
Pag-aaral para sa Colorectal Cancer sa ibang lungsod
- Houston, TX102 pag-aaral
- New York City, NY78 pag-aaral
- Nashville, TN69 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA59 pag-aaral
- Arlington, VA52 pag-aaral
- St. Louis, MO50 pag-aaral
- San Antonio, TX46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Grand Rapids, MI40 pag-aaral
- Baldwin Park, CA37 pag-aaral
- Chicago, IL34 pag-aaral
Iba pang pag-aaral sa Omaha
- Kanser sa Prostate27 pag-aaral
- Non-Small Cell Lung Cancer24 pag-aaral
- Kanser sa Suso22 pag-aaral
- Kanser (lahat ng uri)18 pag-aaral
- Multiple Myeloma16 pag-aaral
- Kanser sa Ovary14 pag-aaral
- Non-Hodgkin Lymphoma14 pag-aaral
- Kanser sa Pancreas14 pag-aaral
- Metastatic Cancer13 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg13 pag-aaral
- Pagkabigo ng Puso13 pag-aaral
- Melanoma12 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.